Cases 71 - 80 of 220
HORIZON ORPHAN LLC et al v. LUPIN LIMITED et al
as 1:2020cv10339
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Plaintiff:
HORIZON THERAPEUTICS USA, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and HORIZON ORPHAN LLC
Cause Of Action: 28 U.S.C. § 1338
Merck Sharp & Dohme Corp. v. Lupin Limited et al
as 1:2020cv00776
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA. S.A. et al v. Lupin Limited et al
as 1:2020cv00782
Plaintiff:
Bial - Holding, S.A., BIAL - PORTELA & CA. S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company v. Lupin Limited et al
as 1:2020cv00854
Defendant:
Lupin Limited, Lupin Inc. and Lupin Pharmaceuticals, Inc.
Plaintiff:
Bristol-Myers Squibb Company
Cause Of Action: 35 U.S.C. § 1
MERCK SHARP & DOHME B.V. et al v. LUPIN LIMITED et al
as 2:2020cv02786
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Plaintiff:
MERCK SHARP & DOHME B.V, ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al
as 1:2020cv00697
Defendant:
Lupin Atlantis Holdings SA, Lupin Limited and Lupin Pharmaceuticals, Inc.
Plaintiff:
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2020cv00415
Defendant:
Lupin Limited, Lupin Inc., Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. LUPIN LTD. et al
as 3:2020cv02744
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
LUPIN LTD. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2020cv00293
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
